CRONIC-PPF.at

Welcome

Description

Projects

Education

Faculty

• Bärnthaler
• Biasin
• Böhm
• Gorkiewicz
• Heinemann
• Heitzer
• Kargl
• Kneidinger
• Kovács
• Kwapiszewska
• Marsh
• Milger
• Sattler
• Singer
• Vesely

Supporting Members

Students

Publications

 

• Webmaster

The CRONIC-PPF Faculty

Thomas BÄRNTHALER
Ass.-Prof. Priv.-Doz. Dr.med.univ. PhD

Peripheral blood signatures of antifibrotics in patients with progressive pulmonary fibrosis

Head of Research Unit "Molecular Pharmacology in Pulmonary Diseases"

Division of Pharmacology, Otto Loewi Research Centre, Medical University of Graz, Neue Stiftingtalstraße 6, 8010 Graz
Phone: +43-316-385 74106, ✉ e-mail

WWW: Forschungsportal Med Uni Graz
ORCID: 0000-0002-4988-3700
PubMed: PubMed (nih.gov)

• Profile      • Curriculum vitae     • Publications    
Education:
2025 Board Certification in Pharmacology and Toxicology
2023 Habilitation in Pharmacology
2015 –2019 PhD thesis, PhD program DK-Molin at the Medical University of Graz, Austria
2009 –2014 Studies of Medicine, M.D., Medical University of Graz
Positions:
2025 – present Head of Research Unit "Molecular Pharmacology in Pulmonary Diseases"
2021 – 2025 Post-doctoral Research Fellow at the Division of Pharmacology, Medical University of Graz, Austria
2020 – 2021 Post-doctoral Research Fellow, Kaminski Lab, Yale School of Medicine
2019 – 2021 Post-doctoral Research Fellow, Otto Loewi Research Center, Division of Pharmacology, Medical University of Graz, Austria
2013 – 2014 PhD Student, Institute of Experimental and Clinical Pharmacology, Medical University of Graz, supervised by Ákos Heinemann, MD, and Viktória Kónya, PhD
Significant research achievements and awards (10 most important):
  • The Role of 15-Prostaglandindehydrogenase in Idiopathic Pulmonary Fibrosis, Austrian Academy of Science, Doc-Fellowship, role: project peader (PhD-Student under supervision by Ákos Heinemann) ~112,000 € (2017 – 2020)
  • Thyroid hormone agonism in acute lung injury, FWF, Schrödinger Fellowship Role: project leader (Post-Doc under supervision by Naftali Kaminski) ~50,000 € (2020 – 2021)
  • The involvement of 15-prostaglandindehydrogenase in acute kidney injury, Austrian Academy of Science, Apart-Mint Fellowship, role: project leader, ~145,000 €, (2022 – 2024)
  • Aberrant basaloid cells in idiopathic pulmonary fibrosis, Land Steiermark, Unkonventionelle Forschung, role: project leader, ~100,000 € (2023 – now)
  • Phenotypic changes of eosinophil granulocytes in aging and sex, Stadt Graz, role: project leader, ~12,000 € (2024 – now)
  • Diethysuccinate as a novel therapeutic for IPF, FWF Stand Alone, role: project leader, ~455,000 € (2025)
  • doc.funds: TRP-dependent cation signalling TRPC.at, role: consortium member, total funding: 2,511,814 € (2025)
  • American Thoracic Society Abstract Fellowship
  • Science communication (article: [↗])
  • Science communication (television: [↗])

04.04.2026 CRONIC-PPF · Doctoral Programme “Clinical & Research Oriented Network for Innovative Classification of Progressive Pulmonary Fibrosis”